The DOI matches its Crossref record.
The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's Disease
Abstract
The distribution of neurofibrillary tangles (NFTs) and neuritic plaques (NPs) was mapped in 39 cortical areas of 11 brains of patients with Alzheimer's disease (AD). Whole hemisphere blocks were embedded in polyethylene glycol (Carbowax), sectioned coronally, and stained with thioflavin S and thionin. The densities of NFTs and NPs were assessed using a numerical rating scale for each area. Scores were grouped by type of cortex and by lobe for statistical analysis. Highly significant differences were obtained. For example, limbic periallocortex and allocortex had more NFTs than any other type of cortex. In descending order, the density of NFTs was as follows: periallocortex (area 28) greater than allocortex (subiculum/CA1 zones of hippocampal formation, area 51) greater than corticoid areas (accessory basal nucleus of amygdala, nucleus basalis of Meynert) greater than proisocortex (areas 11, 12, 24, 23, anterior insula, 38, 35) greater than nonprimary association cortex (32, 46, superior temporal sulcus, 40, 39, posterior parahippocampal cortex, 37, 36) greater than primary sensory association cortex (7, 18, 19, 22, 21, 20) greater than agranular cortex (44-5, 8, 6, 4) greater than primary sensory cortex (41-2, 3-1-2, 17). The laminar distribution of NFTs tended to be selective, involving primarily layers III and V of association areas and layers II and IV of limbic periallocortex. There were far more NFTs in both limbic and temporal lobes than in frontal, parietal, and occipital lobes. In general, NPs were more evenly distributed throughout the cortex, with the exceptions of limbic periallocortex and allocortex, which had notably fewer NPs than other cortical areas. Temporal and occipital lobes had the highest NP densities, limbic and frontal lobes had the lowest, and parietal lobe was intermediate. No significant left-right hemispheric differences for NFT or NP densities were found across the population, and there was no relationship between duration of illness and densities of NFTs or NPs. The regional and laminar distribution of NFTs (and, to a lesser degree, that of NPs) suggests a consistent pattern of vulnerability within the cerebral cortices that seems correlated to the hierarchies of cortico-cortical connections. The higher-order association cortices, especially those in the anterior and ventromedial sectors of temporal lobe, are the most vulnerable, while other cortices appear less vulnerable to a degree commensurate with their connectional "distance" (i.e., synapses removed) from the limbic areas.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The EC is affected severely in Alzheimer disease (AD), likely contributing to memory impairment.”
From Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease (1996) · cites this paper as Arnold et al., 1991
In the citing paper
“The EC was chosen because it is highly selectively vulnerable in AD (Hyman et al., 1984(Hyman et al., , 1986;;Arnold et al., 1991;Braak and Braak, 1991;Price et al., 1991;Arriagada et al., 1992a;Fukutani et al., 1995;Solodkin and Van Hoesen, 1996).”
From Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease (1996) · cites this paper as Arnold et al., 1991
In the citing paper
“The midfrontal gyrus cortex (corresponding predominantly to Brodmann area 46) was chosen for semi-quantitative image analyses of AD pathology, cellular and synaptic markers because of its important role in complex cognition and its common neuropathological involvement in the spectrum of AD (Arnold, et al., 1991).”
From Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer’s disease (2013) · cites this paper as Arnold, et al., 1991
In the citing paper
“as this region is the first area of the brain involved by the neurofibrillary pathology of AD(4, 5).”
From Rates of hippocampal atrophy correlate with change in clinical status in aging and AD (2000) · cites this paper as [5]
In the citing paper
“We consider it to be an important clue that most brains from elderly human subjects show abnormalities that fall somewhere along particular continua of pathologic severity (60, 96-100).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [100]
In the citing paper
“In the early stages of Alzheimer’s disease (AD), the most common form of age-related dementia, clinical symptoms (such as memory loss) are caused by the selective degeneration of principal neurons of the entorhinal cortex layer II (ECII), followed by CA1 pyramidal cells in the hippocampus, and pyramidal neurons in neocortical association areas.”
From Selective Neuronal Vulnerability in Alzheimer’s Disease: A Network-Based Analysis (2020) · cites this paper as Arnold et al., 1991
In the citing paper
“In contrast, other brain regions, such as the primary sensory cortices, are relatively resistant to degeneration until later stages of the disease (Arnold et al., 1991; Bussière et al., 2003; Fukutani et al., 2000; Gómez-Isla et al., 1996; Hof and Morrison, 1990; Hyman et al., 1984; Morrison and Hof, 1997; West et al., 1994).”
From Selective Neuronal Vulnerability in Alzheimer’s Disease: A Network-Based Analysis (2020) · cites this paper as Arnold et al., 1991
Citations
Cites
Still being checked.
Cited by
Sorted by citations
Items 401–500 of 1,002
Tau prion-like propagation: state of the art and current challenges
Dujardin, S., & Hyman, B. T. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-32-9358-8_23 · Cited by 84
Self-citationSani, S., Traul, D., Klink, A., Niaraki, N., Gonzalo-Ruiz, A., Wu, C.-K., & Geula, C. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0626-5 · Cited by 83
Oeltzschner, G., Wijtenburg, S. A., Mikkelsen, M. E., Edden, R. A. E., Barker, P. B., Joo, J. H., Leoutsakos, J., Rowland, L. M., Workman, C. I., & Smith, G. S. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.09.027 · Cited by 83
Eskander, M. F., Nagykery, N. G., Leung, E. Y., Khelghati, B., & Geula, C. (2005) · Brain Research · doi:10.1016/j.brainres.2005.08.039 · Cited by 83
Selective Disruption of the Cerebral Neocortex in Alzheimer's Disease
Desikan, R. S., Sabuncu, M. R., Schmansky, N. J., Reuter, M., Cabral, H., Hess, C. P., Weiner, M. W., Biffi, A., Anderson, C. D., Rosand, J. M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012853 · Cited by 83
Cook, C., Kang, S. S., Carlomagno, Y., Lin, W.-L., Yue, M., Kurti, A., Shinohara, M., Jansen-West, K., Perkerson, E., Castanedes-Casey, M., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv336 · Cited by 82
Quantitative neurohistological features of frontotemporal degeneration
Arnold, S. E., Han, L.-Y., Clark, C. M., Grossman, M., & Trojanowski, J. Q. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00173-1 · Cited by 82
Self-citationCurrent state and future directions of neurochemical biomarkers for Alzheimer's disease
de Jong, D., Kremer, B. P. H., Rikkert, M. G. M. O., & Verbeek, M. M. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.320 · Cited by 84
Holzer, M., Holzapfel, H.-P., Zedlick, D., Brückner, M. K., & Arendt, T. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90546-0 · Cited by 83
Falke, E., Nissanov, J., Mitchell, T. W., Bennett, D. A., Trojanowski, J. Q., & Arnold, S. E. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63518-3 · Cited by 82
Self-citationSustained Attention in Mild Alzheimer's Disease
Berardi, A. M., Parasuraman, R., & Haxby, J. V. (2005) · Developmental Neuropsychology · doi:10.1207/s15326942dn2801_4 · Cited by 81
Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice
Perez, S. E., He, B., Muhammad, N., Oh, K.-J., Fahnestock, M., Ikonomovic, M. D., & Mufson, E. J. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.10.002 · Cited by 80
Ota, M., Sato, N., Nakaya, M., Shigemoto, Y., Kimura, Y., Chiba, E., Yokoi, Y., Tsukamoto, T., & Matsuda, H. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220534 · Cited by 80
Cortical Orofacial Motor Representation in Old World Monkeys, Great Apes, and Humans
Sherwood, C., Holloway, R., Erwin, J., Schleicher, A., Zilles, K., & Hof, P. (2004) · Brain, Behavior and Evolution · doi:10.1159/000075672 · Cited by 101
Runaway synaptic modification in models of cortex: Implications for Alzheimer's disease
Hasselmo, M. E. (1994) · Neural Networks · doi:10.1016/0893-6080(94)90053-1 · Cited by 80
Transcriptional and conformational changes of the tau molecule in Alzheimer's disease
Hyman, B. T., Augustinack, J. C., & Ingelsson, M. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.06.015 · Cited by 79
Self-citationSpallazzi, M., Dobisch, L., Becke, A., Berron, D., Stucht, D., Oeltze‐Jafra, S., Caffarra, P., Speck, O., & Düzel, E. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.11.019 · Cited by 85
DeCarli, C. S., Murphy, D., McIntosh, A. R., Teichberg, D., Schapiro, M. B., & Horwitz, B. (1995) · Psychiatry Research · doi:10.1016/0165-1781(95)02651-c · Cited by 79
Innateness, autonomy, universality? Neurobiological approaches to language
Müller, R. (1996) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00043296 · Cited by 79
Ghosh, A., Mizuno, K., Tiwari, S. S., Proitsi, P., Gomez Perez-Nievas, B., Glennon, E., Martinez-Nunez, R. T., & Giese, K. P. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00882-7 · Cited by 78
Neurotoxic β-amyloid oligomers cause mitochondrial dysfunction—the trigger for PANoptosis in neurons
Meng, X., Song, Q., Liu, Z., Liu, X., Wang, Y., & Liu, J. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1400544 · Cited by 84
Marín‐Padilla, M., & Knopman, D. S. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31823ac627 · Cited by 78
Delano‐Wood, L., Stricker, N. H., Sorg, S. F., Nation, D. A., Jak, A. J., Woods, S. P., Libon, D. J., Delis, D. C., Frank, L. R., & Bondi, M. W. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-102103 · Cited by 79
Giannakopoulos, P., Hof, P. R., Giannakopoulos, A.-S., Herrmann, F. R., Michel, J.-P., & Bouras, C. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540360028012 · Cited by 78
Anatomy of the medial temporal lobe
Hoesen, G. W. V. (1995) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(95)02012-i · Cited by 82
Novel Method to Quantify Neuropil Threads in Brains from Elders With or Without Cognitive Impairment
Mitchell, T. W., Nissanov, J., Han, L.-Y., Mufson, E. J., Schneider, J. A., Cochran, E. J., Bennett, D. A., Lee, V. M.-Y., Trojanowski, J. Q., & Arnold, S. E. (2000) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540004801206 · Cited by 78
Self-citationApostolova, L. G., Zarow, C., Biado, K., Hurtz, S., Boccardi, M., Somme, J. H., Honarpisheh, H., Blanken, A. E., Brook, J. K., Tung, S., et al. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.01.001 · Cited by 77
Touma, C., Ambrée, O., Goertz, N., Keyvani, K., Lewejohann, L., Palme, R., Paulus, W., Schwarze-Eicker, K., & Sachser, N. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.09.004 · Cited by 78
Absence of neurodegeneration in the thalamus and caudate of elderly patients with schizophrenia
Falke, E., Han, L.-Y., & Arnold, S. E. (2000) · Psychiatry Research · doi:10.1016/s0165-1781(00)00104-9 · Cited by 77
Self-citationLim, H. J., Shim, S. B., Jee, S. W., Lee, S. H., Lim, C. J., Hong, J. T., Sheen, Y. Y., & Hwang, D. Y. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.10.005 · Cited by 77
An ‘anatomical cascade hypothesis’ for Alzheimer's disease
Hardy, J. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90033-5 · Cited by 81
Shin, J., Lee, S., Kim, S. J., Kim, S., Cho, S., & Kim, Y.-B. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.04.013 · Cited by 76
The genie in the bottle-magnified calcium signaling in dorsolateral prefrontal cortex
Arnsten, A. F. T., Datta, D., & Wang, M. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00973-3 · Cited by 79
Depth Perception in Alzheimer's Disease
Mendez, M. F., Cherrier, M. M., & Meadows, R. S. (1996) · Perceptual and Motor Skills · doi:10.2466/pms.1996.83.3.987 · Cited by 76
Auditory function in Alzheimer's disease
Kurylo, D. D., Corkin, S., Allard, T., Zatorre, R. J., & Growdon, J. H. (1993) · Neurology · doi:10.1212/wnl.43.10.1893 · Cited by 76
Neural substrates of cognitive and behavioral deficits in atypical Alzheimer's disease
von Gunten, A., Bouras, C., Kövari, E., Giannakopoulos, P., & Hof, P. R. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.11.003 · Cited by 75
Whittington, A., Sharp, D. J., & Gunn, R. N. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.194720 · Cited by 78
Wang, X., Zhang, M., & Liu, H. (2019) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2018.1562874 · Cited by 75
Traumatic brain injury: cause or risk of Alzheimer’s disease? A review of experimental studies
Szczygielski, J., Mautes, A. E. M., Steudel, W. I., Falkai, P., Bayer, T. A., & Wirths, O. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0326-0 · Cited by 75
Arnsten, A. F. T., Datta, D., Leslie, S., Yang, S.-T., Wang, M., & Nairn, A. C. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1903671116 · Cited by 74
Rudrauf, D. (2014) · Advances in Neuroscience · doi:10.1155/2014/462765 · Cited by 74
Diffusion tensor changes in patients with amnesic mild cognitive impairment and various dementias
Chen, T., Lin, C.-C., Chen, Y., Liu, H., Hua, M., Huang, Y., & Chiu, M. (2009) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2008.09.002 · Cited by 74
Hyman, B. T., & Gómez‐Isla, T. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90031-0 · Cited by 74
Self-citationArnold, S. E., Smutzer, G., Trojanowski, J. Q., & Moberg, P. J. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10656.x · Cited by 77
Self-citationSergeant, N., David, J. ‐., Goedert, M., Jakes, R., Vermersch, P., Buée, L., Lefranc, D., Wattez, A., & Delacourte, A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69020834.x · Cited by 79
Gray and white matter degeneration revealed by diffusion in an Alzheimer mouse model
Zerbi, V., Kleinnijenhuis, M., Fang, X., Jansen, D., Veltien, A., Van Asten, J., Timmer, N., Dederen, P. J., Kiliaan, A. J., & Heerschap, A. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.017 · Cited by 74
Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex
Sepulcre, J., Grothe, M. J., Sabuncu, M., Chhatwal, J., Schultz, A. P., Hanseeuw, B., El Fakhri, G., Sperling, R., & Johnson, K. A. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.0263 · Cited by 73
Putcha, D., Brickhouse, M. J., Wolk, D. A., & Dickerson, B. C. (2019) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2019.03.015 · Cited by 80
A single-cell and spatial RNA-seq database for Alzheimer’s disease (ssREAD)
Wang, C., Acosta, D., McNutt, M., Bian, J., Ma, A., Fu, H., & Ma, Q. (2024) · Nature Communications · doi:10.1038/s41467-024-49133-z · Cited by 73
Donix, M., Burggren, A. C., Scharf, M., Marschner, K., Suthana, N., Siddarth, P., Krupa, A. K., Jones, M., Martin‐Harris, L., Ercoli, L. M., et al. (2013) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2013.09.006 · Cited by 73
Cortical Gyrification and Sulcal Spans in Early Stage Alzheimer's Disease
Liu, T., Lipnicki, D. M., Zhu, W., Tao, D., Chengqi Zhang, B., Cui, Y. J., Jin, J. S., Sachdev, P. S., & Wen, W. X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031083 · Cited by 73
New Neuropathological Criteria for Alzheimer Disease
Hyman, B. T. (1998) · Archives of Neurology · doi:10.1001/archneur.55.9.1174 · Cited by 73
Self-citationChapter 26 Reduced neuronal activity and reactivation in Alzheimer's disease
Swaab, D. F., Lucassen, P. J., Salehi, A., Scherder, E., Someren, E. J. W. V., & Verwer, R. W. H. (1998) · Progress in brain research · doi:10.1016/s0079-6123(08)64027-3 · Cited by 74
Auditory object cognition in dementia
Goll, J. C., Kim, L. G., Hailstone, J. C., Lehmann, M., Buckley, A. H., Crutch, S. J., & Warren, J. D. (2011) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2011.06.004 · Cited by 72
Wang, Y., & Mattson, M. P. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.07.007 · Cited by 72
Augustinack, J. C., Sanders, J. L., Tsai, L., & Hyman, B. T. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.6.557 · Cited by 74
Self-citationMapping the effect of APOE ε4 on gray matter loss in Alzheimer's disease in vivo
Pievani, M., Rasser, P. E., Galluzzi, S., Benussi, L., Ghidoni, R., Sabattoli, F., Bonetti, M., Binetti, G. G., Thompson, P. M., & Frisoni, G. B. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.01.009 · Cited by 71
Dynamic regulation of BDNF and NT-3 expression during visual system development
Lein, E. S., Hohn, A., & Shatz, C. J. (2000) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(20000424)420:1 · Cited by 74
Identifying severely atrophic cortical subregions in Alzheimer's disease
Halliday, G. M. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00227-0 · Cited by 72
Disrupted Pattern of D2 Dopamine Receptors in the Temporal Lobe in Schizophrenia
Goldsmith, S. K. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190077008 · Cited by 71
The cortical topography of temporal lobe hypometabolism in early Alzheimer's disease
Jagust, W. J., Eberling, J. L., Richardson, B. C., Reed, B., Baker, M. G., NORDAHL, T. E., & Budinger, T. F. (1993) · Brain Research · doi:10.1016/0006-8993(93)91320-r · Cited by 71
Color Discrimination Performance in Patients with Alzheimer’s Disease
Salamone, G., Lorenzo, C. D., Mosti, S., Lupo, F., Cravello, L., Palmer, K., Musicco, M., & Caltagirone, C. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000218366 · Cited by 70
Familial Alzheimer's disease: Site of mutation influences clinical phenotype
Lippa, C. F., Swearer, J. M., Kane, K., Nochlin, D., Bird, T. D., Ghetti, B. F., Nee, L. E., George‐Hyslop, P. S., Pollen, D. A., & Drachman, D. A. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200009)48:3 · Cited by 67
Sensory cortical interactions in aging, mild cognitive impairment, and Alzheimer’s disease
Golob, E. J., Miranda, G. G., Johnson, J. K., & Starr, A. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00244-5 · Cited by 70
Cecchi, M., Moore, D. K., Sadowsky, C., Solomon, P. R., Doraiswamy, P. M., Smith, C. D., Jicha, G. A., Budson, A. E., Arnold, S. E., & Fadem, K. C. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.08.004 · Cited by 74
Self-citationMismatch negativity during attend and ignore conditions in Alzheimer's disease
Kazmerski, V. A., Friedman, D., & Ritter, W. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00344-7 · Cited by 71
Talbot, K., Young, R., Jolly-Tornetta, C., Lee, V. M. ‐., Trojanowski, J. Q., & Wolf, B. A. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(00)00006-1 · Cited by 69
Hwang, D. Y., Cho, J. S., Lee, S. H., Chae, K. R., Lim, H. J., Min, S. H., Seo, S. J., Song, Y. S., Song, C. W., Paik, S. G., et al. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2003.09.021 · Cited by 69
Differential Neuropsychiatric Symptom Responses to Tacrine in Alzheimer's Disease
Kaufer, D., Cummings, J. L., & Christine, D. (1998) · Journal of Neuropsychiatry · doi:10.1176/jnp.10.1.55 · Cited by 69
Thal, D. R., Schultz, C., Botez, G., Del Tredici, K., Mrak, R. E., Griffin, W. S. T., Wiestler, O. D., Braak, H., & Ghebremedhin, E. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00635.x · Cited by 69
Neurodegeneration and plasticity
Arendt, T. (2004) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.07.007 · Cited by 69
Priming in perceptual identification of pseudowords is normal in Alzheimer's disease
Keane, M. M., Gabrieli, J. D. E., Growdon, J. H., & Corkin, S. (1994) · Neuropsychologia · doi:10.1016/0028-3932(94)90136-8 · Cited by 69
Stothart, G., Kazanina, N., Näätänen, R., Haworth, J., & Tales, A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-140930 · Cited by 68
Lowe, J. S., Mirra, S. S., Hyman, B. T., & Dickson, D. W. (2008) · CRC Press eBooks · doi:10.1201/b13319-15 · Cited by 68
Self-citationZhao, Y., Raichle, M. E., Wen, J., Benzinger, T. L. S., Fagan, A. M., Hassenstab, J. J., Vlassenko, A. G., Luo, J., Cairns, N. J., Christensen, J. J., et al. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.12.026 · Cited by 69
Neuropathology of Alzheimer's Disease
Mott, R. T., & Hulette, C. M. (2005) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2005.09.003 · Cited by 71
Tau PET imaging predicts cognition in atypical variants of Alzheimer's disease
Phillips, J. S., Das, S. R., McMillan, C. T., Irwin, D. J., Roll, E. E., Da Re, F., Nasrallah, I. M., Wolk, D. A., & Grossman, M. (2018) · Human Brain Mapping · doi:10.1002/hbm.23874 · Cited by 68
Advances in the development of tau PET radiotracers and their clinical applications
Okamura, N., Harada, R., Furukawa, K., Furumoto, S., Tago, T., Yanai, K., Arai, H., & Kudo, Y. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2015.12.010 · Cited by 68
Pathogenesis of Alzheimer’s Disease
Castellani, R. J., & Perry, G. L. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_162 · Cited by 67
Vasavada, M. M., Martinez, B., Wang, J., Eslinger, P. J., Gill, D. J., Sun, X., Karunanayaka, P., & Yang, Q. X. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170310 · Cited by 67
Vickers, J. C., Morrison, J., Friedrich, V., Elder, G., Perl, D., Katz, R., & Lazzarini, R. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-09-05603.1994 · Cited by 67
Selective Secretase Targeting for Alzheimer’s Disease Therapy
Miranda, A., Montiel, E., Ulrich, H., & Paz, C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201027 · Cited by 66
Amyloid Deposition in Early Onset versus Late Onset Alzheimer's Disease
Cho, H., Seo, S. W., Kim, J., Suh, M. K., Lee, J., Choe, Y. S., Lee, K.-H., Kim, J. S., Kim, G. H., Noh, Y., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121927 · Cited by 69
Involvement of cysteinyl leukotriene receptor 1 in Aβ1–42-induced neurotoxicity in vitro and in vivo
Tang, S., Hong, H., Chen, L., Mei, Z.-L., Ji, M., Xiang, G., Li, N., & Ji, H. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.036 · Cited by 67
Mosconi, L., Rinne, J. O., Tsui, W. H., Murray, J., Li, Y., Glodzik, L., McHugh, P. F., Williams, S., Cummings, M., Pirraglia, E., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.03.002 · Cited by 69
β-Amyloid Induces Pathology-Related Patterns of Tau Hyperphosphorylation at Synaptic Terminals
Wu, H., Kuo, P.-C., Wang, Y.-T., Lin, H.-T., Roe, A. D., Wang, B. Y., Han, C., Hyman, B. T., Chen, Y., & Tai, H. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly059 · Cited by 72
Self-citationPerspectives on the Amyloid-β Cascade Hypothesis
Lee, H., Casadesús, G., Zhu, X., Joseph, J. A., Perry, G. L., & Smith, M. A. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6205 · Cited by 66
Alzheimer's disease-related synapse loss in the cingulate cortex
Scheff, S. W., & PRICE, D. A. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3509 · Cited by 68
Entorhinal—hippocampal interaction in mnestic disorders
Braak, H., & Braak, E. (1993) · Hippocampus · doi:10.1002/hipo.1993.4500030727 · Cited by 66
Modulation of Aβ Deposition in APP Transgenic Mice by an Apolipoprotein E Null Background
IRIZARRY, M. C., REBECK, G. W., CHEUNG, B., BALES, K., PAUL, S. M., HOLZMAN, D., & HYMAN, B. T. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06919.x · Cited by 66
Self-citationWhite matter integrity linked to functional impairments in aging and early Alzheimer’s disease
Kavcic, V., Ni, H., Zhu, T., Zhong, J., & Duffy, C. J. (2008) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2008.07.001 · Cited by 65
Carlyle, B. C., Kandigian, S. E., Kreuzer, J., Das, S., Trombetta, B. A., Kuo, Y., Bennett, D. A., Schneider, J. A., Petyuk, V. A., Kitchen, R. R., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.04.012 · Cited by 65
Self-citationTredici, K. D., & Braak, H. (2019) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2019.11.008 · Cited by 68
García‐Cabezas, M. Á., Hacker, J. L., & Zikopoulos, B. (2020) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2020.576015 · Cited by 67
The Enigma of Tau Protein Aggregation: Mechanistic Insights and Future Challenges
Zheng, H., Sun, H., Cai, Q., & Tai, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094969 · Cited by 69
Cytoarchitectonic alterations in the supramarginal gyrus of late onset Alzheimer's disease
Grignon, Y., Duyckaerts, C. J., Bennecib, M., & Hauw, J. (1998) · Acta Neuropathologica · doi:10.1007/s004010050816 · Cited by 65
Dam, D. V., Vermeiren, Y., Dekker, A. D., Naudé, P. J. W., & Deyn, P. P. D. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160502123607 · Cited by 68
Prion-like mechanisms in Alzheimer disease
Walker, L. C. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63945-5.00016-7 · Cited by 67
Kurylo, D. D., Corkin, S., F., I. R. J., & Growdon, J. H. (1996) · Neuropsychology · doi:10.1037/0894-4105.10.1.74 · Cited by 65
Broad-band visual capacities are not selectively impaired in Alzheimer's disease
Kurylo, D. D., Corkin, S., Dolan, R. P., Rizzo, J. F., Parker, S. W., & Growdon, J. H. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90025-6 · Cited by 65
Metadata
- Authors
- Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W.
- Affiliations
- University of Iowa (US)
- Venue
- Cerebral Cortex
- Publisher
- Oxford University Press (OUP)
- Published
- 1991-01-01
- Volume
- 1
- Issue
- 1
- Pages
- 103-116
- ISSN
- 1047-3211 (ISSN-L)
- 1460-2199
- OpenAlex
- W2029923284
- Cited by
- 1,380
- References
- 0
- Citations by year
- 2026: 15 · 2025: 32 · 2024: 32 · 2023: 34 · 2022: 31 · 2021: 45 · 2020: 36 · 2019: 41 · 2018: 47 · 2017: 43 · 2016: 42 · 2015: 40 · 2014: 42 · 2013: 54 · 2012: 42
- FWCI
- 19.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cerebral Cortex (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (P019632)
- National Institute on Aging (AG-08487)
- National Institute of Neurological Disorders and Stroke (R01NS014944, NS-14944)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, neurofibrillary tangles, neuritic plaques, cortical topography, neuroanatomy, allocortex, temporal lobe, occipital lobe, frontal lobe, parietal lobe, laminar distribution, thioflavin S, thionin, amygdala, nucleus basalis of Meynert
- MeSH terms
- Aged, Alzheimer Disease, Brain Mapping, Cerebral Cortex, Female, Histocytochemistry, Humans, Male, Middle Aged, Neurites, Tissue Embedding, Neurofibrillary Tangles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
